E-eso) http://www.e-eso.net European School Oncology GR182 - Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers http://www.e-eso.net/egrandround.do?methodcall=details&id=212 Wed, 08 Feb 2012 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=212 2012-02-08T23:00:00Z GR16 - Cardiac side effects of molecular targeted therapies: Towards a better dialogue between oncologists and cardiologists (based on a review article of Critical Reviews in Oncology Hematology) http://www.e-eso.net/egrandround.do?methodcall=details&id=208 Mon, 06 Feb 2012 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=208 2012-02-06T23:00:00Z GR181 - Physicians' communication and interpersonal skills in sharing decision-making process with prostate cancer patients http://www.e-eso.net/egrandround.do?methodcall=details&id=207 Wed, 01 Feb 2012 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=207 2012-02-01T23:00:00Z GR180 - Imatinib: gonadal and fetal effect http://www.e-eso.net/egrandround.do?methodcall=details&id=205 Wed, 25 Jan 2012 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=205 2012-01-25T23:00:00Z GR179 - How EU policy affects cancer research across Europe and how we can try to influence it http://www.e-eso.net/egrandround.do?methodcall=details&id=201 Wed, 18 Jan 2012 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=201 2012-01-18T23:00:00Z GR15 - Implications of multigene assay for DCIS on current treatment patterns http://www.e-eso.net/egrandround.do?methodcall=details&id=234 Mon, 16 Jan 2012 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=234 2012-01-16T23:00:00Z GR178 - Osteosarcoma: Recent trials and implications for future studies http://www.e-eso.net/egrandround.do?methodcall=details&id=179 Wed, 11 Jan 2012 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=179 2012-01-11T23:00:00Z GR177 - Advanced Breast Cancer First Consensus Conference: Highlights and guidelines http://www.e-eso.net/egrandround.do?methodcall=details&id=151 Wed, 14 Dec 2011 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=151 2011-12-14T23:00:00Z GR176 - Lessons learned from recent trials in NET with special focus on pNET http://www.e-eso.net/egrandround.do?methodcall=details&id=217 Wed, 07 Dec 2011 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=217 2011-12-07T23:00:00Z GR14 - Inhibiting JAK 1/2 pathway as a novel approach to treatment of primary and secondary myelofibrosis http://www.e-eso.net/egrandround.do?methodcall=details&id=219 Mon, 05 Dec 2011 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=219 2011-12-05T23:00:00Z GR175 - Synergy among Breast Units: the SenoNetwork Project http://www.e-eso.net/egrandround.do?methodcall=details&id=200 Wed, 30 Nov 2011 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=200 2011-11-30T23:00:00Z GR174 - New insights in bone and androgen deprivation therapies in prostate cancer http://www.e-eso.net/egrandround.do?methodcall=details&id=174 Wed, 23 Nov 2011 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=174 2011-11-23T23:00:00Z GR173 - Extragonadal germ cell tumours in children: Who is really high risk and how should we treat these patients? (held in co-operation with SIOP-E) http://www.e-eso.net/egrandround.do?methodcall=details&id=187 Wed, 16 Nov 2011 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=187 2011-11-16T23:00:00Z GR172 - What's new in the management of breast cancer brain metastasis? http://www.e-eso.net/egrandround.do?methodcall=details&id=176 Wed, 09 Nov 2011 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=176 2011-11-09T23:00:00Z GR13 - The use of rapid onset opioids for breakthrough cancer pain: The challenge of its dosing (based on a review article of Critical Reviews in Oncology Hematology) http://www.e-eso.net/egrandround.do?methodcall=details&id=216 Mon, 07 Nov 2011 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=216 2011-11-07T23:00:00Z GR171 - Chronic lymphocytic leukaemia first line treatment: How far should we go to achieve negative MRD? http://www.e-eso.net/egrandround.do?methodcall=details&id=182 Wed, 02 Nov 2011 23:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=182 2011-11-02T23:00:00Z GR170 - Endotherapy for Barrett's esophagus with early neoplasia http://www.e-eso.net/egrandround.do?methodcall=details&id=203 Wed, 26 Oct 2011 22:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=203 2011-10-26T22:00:00Z GR169 - Treating prostate cancer with radiotherapy (based on a Review article of Nature Reviews Clinical Oncology) http://www.e-eso.net/egrandround.do?methodcall=details&id=184 Wed, 19 Oct 2011 22:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=184 2011-10-19T22:00:00Z GR168 - Radiotherapy after mastectomy: Can we avoid it? http://www.e-eso.net/egrandround.do?methodcall=details&id=180 Wed, 12 Oct 2011 22:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=180 2011-10-12T22:00:00Z GR167 - How to manage patients with intermediate stage hepatocellular carcinoma http://www.e-eso.net/egrandround.do?methodcall=details&id=185 Wed, 05 Oct 2011 22:00:00 GMT http://www.e-eso.net/egrandround.do?methodcall=details&id=185 2011-10-05T22:00:00Z